1. Chatterjee S, QbD considerations for analytical methods—FDA perspective, presented at the IFPAC annual meeting, Baltimore, 2013, CMC Lead for QbD ONDQA/CDER/FDA
2. QbD approaches to analytical methods—FDA Perspective;Yubing Tang,2011
3. J. Ermer, Quality by design in pharmaceutical analysis, Conference organized by European Compliance Academy, Vienna, Austria.
4. International Conference on Harmonization (ICH) Tripartite Guidelines, 2009. ICH Q8(R2): Pharmaceutical Development
5. International Conference on Harmonization (ICH) Tripartite Guidelines, 2006. ICH Q9: Quality Risk Management.